Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

    Results: 1 to 20 of 84

    1.

    Expression of genes involved in fatty acid transport and insulin signaling is altered by physical inactivity and exercise training in human skeletal muscle.

    Lammers G, Poelkens F, van Duijnhoven NT, Pardoel EM, Hoenderop JG, Thijssen DH, Hopman MT.

    Am J Physiol Endocrinol Metab. 2012 Nov 15;303(10):E1245-51. doi: 10.1152/ajpendo.00356.2012. Epub 2012 Sep 25.

    PMID:
    23011062
    [PubMed - indexed for MEDLINE]
    2.

    Bezafibrate can be a new treatment option for mitochondrial fatty acid oxidation disorders: evaluation by in vitro probe acylcarnitine assay.

    Yamaguchi S, Li H, Purevsuren J, Yamada K, Furui M, Takahashi T, Mushimoto Y, Kobayashi H, Hasegawa Y, Taketani T, Fukao T, Fukuda S.

    Mol Genet Metab. 2012 Sep;107(1-2):87-91. doi: 10.1016/j.ymgme.2012.07.004. Epub 2012 Jul 14.

    PMID:
    22841441
    [PubMed - indexed for MEDLINE]
    3.

    PGC-1β regulates mouse carnitine-acylcarnitine translocase through estrogen-related receptor α.

    Gacias M, Pérez-Martí A, Pujol-Vidal M, Marrero PF, Haro D, Relat J.

    Biochem Biophys Res Commun. 2012 Jul 13;423(4):838-43. doi: 10.1016/j.bbrc.2012.06.051. Epub 2012 Jun 16.

    PMID:
    22713466
    [PubMed - indexed for MEDLINE]
    4.

    Ablation of steroid receptor coactivator-3 resembles the human CACT metabolic myopathy.

    York B, Reineke EL, Sagen JV, Nikolai BC, Zhou S, Louet JF, Chopra AR, Chen X, Reed G, Noebels J, Adesina AM, Yu H, Wong LJ, Tsimelzon A, Hilsenbeck S, Stevens RD, Wenner BR, Ilkayeva O, Xu J, Newgard CB, O'Malley BW.

    Cell Metab. 2012 May 2;15(5):752-63. doi: 10.1016/j.cmet.2012.03.020.

    PMID:
    22560224
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    5.

    Diagnosis of disorders of intermediary metabolism in New Zealand before and after expanded newborn screening: 2004-2009.

    Wilson C, Kerruish NJ, Wilcken B, Wiltshire E, Bendikson K, Webster D.

    N Z Med J. 2012 Jan 20;125(1348):42-50.

    PMID:
    22282276
    [PubMed - indexed for MEDLINE]
    6.

    The mitochondrial carnitine/acylcarnitine carrier: function, structure and physiopathology.

    Indiveri C, Iacobazzi V, Tonazzi A, Giangregorio N, Infantino V, Convertini P, Console L, Palmieri F.

    Mol Aspects Med. 2011 Aug;32(4-6):223-33. doi: 10.1016/j.mam.2011.10.008. Epub 2011 Oct 15. Review.

    PMID:
    22020112
    [PubMed - indexed for MEDLINE]
    7.

    Expanded molecular features of carnitine acyl-carnitine translocase (CACT) deficiency by comprehensive molecular analysis.

    Wang GL, Wang J, Douglas G, Browning M, Hahn S, Ganesh J, Cox S, Aleck K, Schmitt ES, Zhang W, Wong LJ.

    Mol Genet Metab. 2011 Aug;103(4):349-57. doi: 10.1016/j.ymgme.2011.05.001. Epub 2011 May 7.

    PMID:
    21605995
    [PubMed - indexed for MEDLINE]
    8.

    Analysis of inborn errors of metabolism: disease spectrum for expanded newborn screening in Hong Kong.

    Lee HC, Mak CM, Lam CW, Yuen YP, Chan AO, Shek CC, Siu TS, Lai CK, Ching CK, Siu WK, Chen SP, Law CY, Tai HL, Tam S, Chan AY.

    Chin Med J (Engl). 2011 Apr;124(7):983-9.

    PMID:
    21542954
    [PubMed - indexed for MEDLINE]
    Free Article
    9.

    Carnitine-acylcarnitine translocase deficiency. Clinical course of 3 Saudi children with a severe phenotype.

    Al-Mendalawi MD.

    Saudi Med J. 2011 Feb;32(2):203; author reply 203. No abstract available.

    PMID:
    21301774
    [PubMed - indexed for MEDLINE]
    10.

    Carnitine-acylcarnitine translocase deficiency. Clinical course of three Saudi children with a severe phenotype.

    Al-Sannaa NA, Cheriyan GM.

    Saudi Med J. 2010 Aug;31(8):931-4.

    PMID:
    20714679
    [PubMed - indexed for MEDLINE]
    11.

    Fatty acid oxidation disorders: outcome and long-term prognosis.

    Wilcken B.

    J Inherit Metab Dis. 2010 Oct;33(5):501-6. doi: 10.1007/s10545-009-9001-1. Epub 2010 Jan 5. Review.

    PMID:
    20049534
    [PubMed - indexed for MEDLINE]
    12.

    Regulation of the human SLC25A20 expression by peroxisome proliferator-activated receptor alpha in human hepatoblastoma cells.

    Tachibana K, Takeuchi K, Inada H, Yamasaki D, Ishimoto K, Tanaka T, Hamakubo T, Sakai J, Kodama T, Doi T.

    Biochem Biophys Res Commun. 2009 Nov 20;389(3):501-5. doi: 10.1016/j.bbrc.2009.09.018. Epub 2009 Sep 11.

    PMID:
    19748481
    [PubMed - indexed for MEDLINE]
    13.

    Mouse carnitine-acylcarnitine translocase (CACT) is transcriptionally regulated by PPARalpha and PPARdelta in liver cells.

    Gutgesell A, Wen G, König B, Koch A, Spielmann J, Stangl GI, Eder K, Ringseis R.

    Biochim Biophys Acta. 2009 Oct;1790(10):1206-16. doi: 10.1016/j.bbagen.2009.06.012. Epub 2009 Jul 3.

    PMID:
    19577614
    [PubMed - indexed for MEDLINE]
    14.

    Multiple splice defects in ABCA1 cause low HDL-C in a family with hypoalphalipoproteinemia and premature coronary disease.

    Rhyne J, Mantaring MM, Gardner DF, Miller M.

    BMC Med Genet. 2009 Jan 8;10:1. doi: 10.1186/1471-2350-10-1.

    PMID:
    19133158
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    15.

    Disorders of the carnitine cycle and detection by newborn screening.

    Wilcken B.

    Ann Acad Med Singapore. 2008 Dec;37(12 Suppl):71-3.

    PMID:
    19904456
    [PubMed - indexed for MEDLINE]
    16.

    Carnitine-palmitoyltransferase 2 deficiency: novel mutations and relevance of newborn screening.

    Illsinger S, Lücke T, Peter M, Ruiter JP, Wanders RJ, Deschauer M, Handig I, Wuyts W, Das AM.

    Am J Med Genet A. 2008 Nov 15;146A(22):2925-8. doi: 10.1002/ajmg.a.32545.

    PMID:
    18925671
    [PubMed - indexed for MEDLINE]
    17.

    Baicalein 5,6,7-trimethyl ether activates peroxisomal but not mitochondrial fatty acid beta-oxidation.

    Morita M, Kanai M, Mizuno S, Iwashima M, Hayashi T, Shimozawa N, Suzuki Y, Imanaka T.

    J Inherit Metab Dis. 2008 Jun;31(3):442-9. doi: 10.1007/s10545-008-0857-2. Epub 2008 May 9.

    PMID:
    18470630
    [PubMed - indexed for MEDLINE]
    18.

    Functional characterization of residues within the carnitine/acylcarnitine translocase RX2PANAAXF distinct motif.

    De Lucas JR, Indiveri C, Tonazzi A, Perez P, Giangregorio N, Iacobazzi V, Palmieri F.

    Mol Membr Biol. 2008 Feb;25(2):152-63. doi: 10.1080/09687680701697476.

    PMID:
    18307102
    [PubMed - indexed for MEDLINE]
    19.

    Characterization of L-aminocarnitine, an inhibitor of fatty acid oxidation.

    Chegary M, Te Brinke H, Doolaard M, Ijlst L, Wijburg FA, Wanders RJ, Houten SM.

    Mol Genet Metab. 2008 Apr;93(4):403-10. Epub 2008 Feb 20.

    PMID:
    18077198
    [PubMed - indexed for MEDLINE]
    20.

    Pre-eclampsia in a woman whose child suffered from lethal carnitine-acylcarnitine translocase deficiency.

    Geven WB, Niezen-Koning KE, Timmer A, van Loon AJ, Wanders RJ, van Spronsen FJ.

    BJOG. 2007 Aug;114(8):1028-30. Epub 2007 Jun 18. No abstract available.

    PMID:
    17578469
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Search details

      See more...

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk